Form 8-K - Current report:
SEC Accession No. 0001493152-18-009498
Filing Date
2018-07-02
Accepted
2018-07-02 06:10:36
Documents
54
Period of Report
2018-06-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 28420
2 ex99-1.htm EX-99.1 50882
3 image_001.jpg GRAPHIC 133760
4 image_002.jpg GRAPHIC 113788
5 image_003.jpg GRAPHIC 121665
6 image_004.jpg GRAPHIC 74806
7 image_005.jpg GRAPHIC 113800
8 image_006.jpg GRAPHIC 68604
9 image_007.jpg GRAPHIC 79700
10 image_008.jpg GRAPHIC 63832
11 image_009.jpg GRAPHIC 95402
12 image_010.jpg GRAPHIC 105056
13 image_011.jpg GRAPHIC 74852
14 image_012.jpg GRAPHIC 64153
15 image_013.jpg GRAPHIC 113552
16 image_014.jpg GRAPHIC 87485
17 image_015.jpg GRAPHIC 96988
18 image_016.jpg GRAPHIC 83099
19 image_017.jpg GRAPHIC 82666
20 image_018.jpg GRAPHIC 121120
21 image_019.jpg GRAPHIC 89962
22 image_020.jpg GRAPHIC 124806
23 image_021.jpg GRAPHIC 99387
24 image_022.jpg GRAPHIC 102001
25 image_023.jpg GRAPHIC 106180
26 image_024.jpg GRAPHIC 138897
27 image_025.jpg GRAPHIC 73268
28 image_026.jpg GRAPHIC 99744
29 image_027.jpg GRAPHIC 102815
30 image_028.jpg GRAPHIC 96493
31 image_029.jpg GRAPHIC 65099
32 image_030.jpg GRAPHIC 80183
33 image_031.jpg GRAPHIC 90424
34 image_032.jpg GRAPHIC 112432
35 image_033.jpg GRAPHIC 95340
36 image_034.jpg GRAPHIC 81803
37 image_035.jpg GRAPHIC 65705
38 image_036.jpg GRAPHIC 94135
39 image_037.jpg GRAPHIC 71865
40 image_038.jpg GRAPHIC 79900
41 image_039.jpg GRAPHIC 74882
42 image_040.jpg GRAPHIC 57126
43 image_041.jpg GRAPHIC 102764
44 image_042.jpg GRAPHIC 77497
45 image_043.jpg GRAPHIC 99121
46 image_044.jpg GRAPHIC 81507
47 image_045.jpg GRAPHIC 101740
48 image_046.jpg GRAPHIC 87794
49 image_047.jpg GRAPHIC 77022
50 image_048.jpg GRAPHIC 81267
51 image_049.jpg GRAPHIC 103603
52 image_050.jpg GRAPHIC 110100
53 image_051.jpg GRAPHIC 73579
54 image_052.jpg GRAPHIC 107280
  Complete submission text file 0001493152-18-009498.txt   6694159
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 18930777
SIC: 7389 Services-Business Services, NEC